Abstract
Although there is lack of consensus regarding the “standard of care” for malignant pleural mesothelioma, surgery-based multimodality therapy has demonstrated long-term survivors in multiple retrospective and prospective trials. The authors advocate radical or extended pleurectomy/decortication when possible, but for patients with adequate cardiopulmonary function in whom disease is resectable only by extrapleural pneumonectomy, this operation now has a long track record of safety and serves a critical role in the treatment of this aggressive disease.
Keywords: Chemotherapy, Extrapleural pneumonectomy, thoracic surgery.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Diabetes Reviews
Current Neurovascular Research
Current Respiratory Medicine Reviews
Current Pediatric Reviews
Infectious Disorders - Drug Targets
Current Stem Cell Research & Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Alzheimer Research
Current Aging Science
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents